Featured news from NHIVNA

HIV-related news from NAM

The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears
Gus Cairns, 2016-10-26 09:00:00

The 2016 Glasgow HIV Conference heard today that over a 20-year period, people who suffered lipodystrophy (fat redistribution) and especially lipoatrophy (fat loss) when they started antiretroviral therapy (ART) actually had better health outcomes than people who did not suffer from it.

The finding, which was contrary to researchers’ expectations, shows that even if lipoatrophy exacted a social and psychological price, because it was a marker for good adherence to HIV treatment, people who developed it had a lower risk of death, AIDS or certain co-morbidities over the next 20 years.